Neutrophil activation during acute human anaphylaxis: analysis of MPO and sCD62LCLINICAL AND EXPERIMENTAL ALLERGYIF5.22017-01-1337OAAI
Immediate-type hypersensitivity drug reactionsBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32014-06-2045OAAI
Anaphylaxis: Clinical features and mediator release patterns ReplyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22013-12-010OAAI
Anaphylaxis: Clinical patterns, mediator release, and severityJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22013-11-01215OA
Immune Response to Snake Envenoming and Treatment with Antivenom; Complement Activation, Cytokine Production and Mast Cell DegranulationPLOS NEGLECTED TROPICAL DISEASESIF3.42013-07-2590OAAI
Ultrarush versus semirush initiation of insect venom immunotherapy: A randomized controlled trialJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22012-07-0143OA
Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactionsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22009-10-01128PRE
An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapyCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82008-07-0742OAAI
Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ARTJOURNAL OF CLINICAL IMMUNOLOGYIF5.72006-03-2824PREAI
HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirusAIDSIF3.12005-04-0830OAAI
Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patientsJOURNAL OF INFECTIOUS DISEASESIF4.52002-11-1547OAAI
Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environmentJOURNAL OF INFECTIOUS DISEASESIF4.52002-06-1552OAAI
Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapyJOURNAL OF INFECTIOUS DISEASESIF4.52001-10-1556OAAI
Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapyJOURNAL OF CLINICAL VIROLOGYIF3.42001-10-0187PREAI
MHC haplotypes affect the expression of opportunistic infections in HIV patientsHUMAN IMMUNOLOGYIF2.22001-02-0154PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向